×
About 484 results
CUVPOSA® (glycopyrrolate) oral solution
http://www.cuvposa.com/

CUVPOSA is an anticholinergic indicated to reduce chronic severe drooling in patients aged 3-16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy).

LYRICA (pregabalin) CAPSULES
https://www1.pfizerpro.com/product/lyrica

See risks and benefits of LYRICA® (pregabalin). Find clinical information about LYRICA Capsules CV, an Rx for FM, pDPN, PHN, & spinal chord injury nerve pain.

Panzyga® (human normal immunoglobulin, IVIg)
https://www.panzyga.info/en/healthcare-professionals.html

Panzyga® is a human normal immunoglobulin solution stabilised with glycine.

DULOXETINE DR
http://camberpharma.com/products/duloxetine-307

Duloxetine is indicated for the treatment of: Major Depressive Disorder; Generalized Anxiety Disorder; Diabetic Peripheral Neuropathy; Fibromyalgia; Chronic Musculoskeletal Pain

ARNICARE® CREAM/GEL
http://www.arnicare.com/about/arnicare-topicals/arnicare-cream/

Before pain gets in your way, relieve it with Arnicare Cream. Temporarily relieves muscle pain and stiffness, swelling from injuries, and bruising.

RADICAVA (edaravone injection)
https://www.radicava.com/hcp/

In the treatment of ALS every move matters. ... Radicava® (edaravone) is contraindicated in patients with a history of hypersensitivity to edaravone or any of the inactive ingredients in Radicava®. ... To report suspected adverse reactions or product complaints, contact Mitsubishi Tanabe ...

THICK IT AQUACAREH2O THICKENED WATER
http://thickit.com/product/thickened-water/

Thickened Water Pre-Thickened Ready to Drink | ThickIt

TIGLUTIK™ (riluzole) - ALS Treatment - Healthcare Professionals
https://www.tiglutik.com/hcp/

Introducing TIGLUTIK (riluzole) Freedom of liquid delivery. The first and only easy-to-swallow form of riluzole

Savella® (milnacipran HCl) Tablets
http://www.savellahcp.com/

Available at: http://www.rheumatology.org/practice/clinical/patients/diseases_and_conditions/fibromyalgia.asp. Accessed May 27, 2014. Savella (milnacipran ...

Lidocaine hci - lidocaine hci injection, solution-HF Acquisition Co LLC, DBA HealthFirst
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=993bc59e-5e71-bd9e-e053-2a95a90af85c

Dec 7th, 2019 - Lidocaine Hydrochloride Injection, USP administered intravenously is specifically indicated in the acute management of 1) ventricular arrhythmias occurring during cardiac manipulation such as cardiac surgery, and 2) life-threatening arrhythmias, particularly those which are ventricular in origin, such as those which occur during acute myocardial infarction.

Oxybutynin chloride - oxybutynin chloride tablet, extended release-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cdcfce4c-d2a1-43b3-8bf5-0ac102d857ae

Dec 5th, 2019 - Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition...

Pregabalin - pregabalin capsule-Sun Pharmaceutical Industries, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee7b9119-e88f-48ad-ae97-55e53374e62f

Dec 3rd, 2019 - Indications & Usage Section Pregabalin capsules are indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pediatric use informa...

Aquestive Therapeutics Receives FDA Approval for Exservan (riluzole) Oral Film
http://aquestive.com/aquestive-therapeutics-receives-fda-approval-for-exservan-riluzole-oral-film/

Nov 24th, 2019 - Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that Exservan™ (riluzole) Oral Film received early-action approval from the U.S. Food and Drug Administration (FDA) for the treatment of amyotrophic lateral sclerosis (ALS), an orphan disease.

Baclofen - baclofen tablet-Major Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae732bdc-5178-4565-8219-d1787a5211a6

Nov 17th, 2019 - Baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen may also be of some value in patients with spinal cord injuries and o...

Pregabalin - pregabalin capsule-Aphena Pharma Solutions - Tennessee, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=297f44e6-914e-4df1-a136-7e11ef4acbcd

Nov 17th, 2019 - Pregabalin is indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pregabalin is indicated for: Neuropathic pain associated wit...

Zidovudine - zidovudine tablet, film coated-Aurobindo Pharma Limited
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e7c8ddef-005d-4f1c-8c1a-ea84044ab4d4

Nov 15th, 2019 - Boxed Warning Section Zidovudine tablets have been associated with hematologic toxicity including neutropenia and severe anemia, particularly in patients with advanced HIV-1 disease [see Warnings and Precautions (5.1)]. Prolonged use of zidovudine has been associated with symptomatic myopathy [see Warnings and Precautions (5.3)].   Lactic acidosis and severe hepatomegaly with steatosis, includi...

Oxybutynin chloride - oxybutynin chloride tablet, extended release-Lake Erie Medical DBA Quality Care Products LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89de3b18-fa75-4b7f-920f-52df15396ec7

Nov 12th, 2019 - Oxybutynin chloride extended-release tablets are muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (...

Cymbalta - duloxetine hydrochloride capsule, delayed release-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1beb5954-fdb2-47d0-9ca1-586df00ba915

Nov 11th, 2019 - CYMBALTA ® is indicated for the treatment of: Major Depressive Disorder [see Clinical Studies ( 14.1)] Generalized Anxiety Disorder [see Clinical Studies ( 14.2)] Diabetic Peripheral Neuropathy [see Clinical Studies ( 14.3)] Fibromyalgia [see Clinical Studies ( 14.4)] Chronic Musculoskeletal Pain [see Clinical Studies ( 14.5)] CYMBALTA ® is a serotonin and norepinephrine reuptake inhibitor (SNR...

Oxybutynin chloride - oxybutynin chloride tablet, extended release-Preferred Pharmaceuticals Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d43e67a7-82f6-42af-83df-50f9b8294feb

Nov 10th, 2019 - Oxybutynin chloride extended-release tablets are muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (...

Pregabalin - pregabalin capsule-Quality Care Products, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c2c53006-de7f-4746-beb1-b9e162b0a5b1

Nov 7th, 2019 - Pregabalin capsules are indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved f...